From the 1Mayo Clinic, Jacksonville, Florida, 2Yale University School of Medicine, New
Haven, Connecticut, 3Cleveland Clinic Lerner College of Medicine of Case Western …

Purpose of review Remote monitoring (RM) of cardiac implantable electronic devices
(CIEDs) is recommended as part of the individualized multidisciplinary follow-up of heart …

Background Implantable cardioverter–defibrillators (ICDs) prevent sudden death from
cardiac causes in selected patients but require the use of transvenous lead systems. To …

Aim Angiotensin converting enzyme 2 (ACE2) is an integral membrane protein whose main
action is to degrade angiotensin II. Plasma ACE2 activity is increased in various …

Background: Transvenous implantable cardioverter-defibrillators (TV-ICDs) improve survival
in patients at risk for sudden cardiac death, but complications remain an important …

Background—Monitoring performance of implantable cardioverter-defibrillator (ICD)
generators and leads is important. Methods available are with in-person evaluations or by …

BACKGROUND: The approval of an entirely subcutaneous implantable-cardioverter
defibrillator (ICD) system (S-ICD) has raised attention about this promising technology. It …

BACKGROUND: The Medtronic Sprint Fidelis defibrillator lead is prone to fracture and was
recalled in 2007 after 665 failures and five reported deaths. Approximately 150,000 patients …

Background Lead extraction has undergone an explosive evolution since its inception as a
rudimentary skill with limited technology and therapeutic options. Early techniques involved …

Aims Therapy with an implantable cardioverter defibrillator (ICD) is established for the
prevention of sudden cardiac death (SCD) in high risk patients. We aimed to determine the …